| Disease | stevens-johnson syndrome |
| Symptom | C1557335|ocular surface disease |
| Sentences | 1 |
| PubMedID- 20929291 | Purpose: at least one-year follow-up of a case series of young stevens-johnson syndrome (sjs) patients with cicatrizing ocular surface disease and recurrent inflammation (sjs-ri) treated with systemic humanized monoclonal antibody (daclizumab). |
Page: 1